癌症疫苗向突变GNAQ表达的卵巢黑色素瘤
Vitali Alexeev1, Mizue Terai1, Sergei Koshkin1
1Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA.
Cancers
|February 13, 2026
概括
这项研究探讨了DNA疫苗,以向膜黑色素瘤 (UM) 中的GNAQ Q209L突变. 这些疫苗激活了T细胞,显示出在UM患者中预防转移性疾病进展的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 卵巢黑色素瘤 (UM) 是成年人中最常见的眼内恶性瘤.
- 虽然初级瘤治疗提供了很高的生存率,但肝转移是常见的,这表明早期的休眠细胞迁移.
- 通过癌症疫苗向休眠细胞可以防止转移性进展.
研究的目的:
- 研究DNA接种疫苗,以激活免疫反应,以对抗UM中GNAQ/GNA11蛋白中的常见Q209L突变.
- 评估癌症疫苗在预防UM患者转移性疾病方面的潜力.
主要方法:
- 开发出编码突变GNAQ的DNA结构.
- 在HLA-A2/Hd转基因小鼠和人类T细胞中测试了T细胞激活的构造.
- 通过测量T细胞反应和对UM细胞的细胞毒性活性来评估疫苗的疗效.
主要成果:
- 具有PADRE和VP22表位的DNA结构增强了T细胞对突变GNAQ的反应.
- 这些反应与减少的实验性肺转移相关.
- 疫苗激活的T细胞在体外表现出对表达突变GNAQ的UM细胞的细胞毒性.
结论:
- 融合DNA疫苗可以引起对具有Q209L突变的UM细胞的T细胞免疫力.
- 这种方法有望防止UM转移性疾病的建立和进展.
相关概念视频
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Vaccinations
51.9K
Overview
51.9K
Mutations
94.6K
Overview
94.6K
Mutations
44.7K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.7K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K


